arrow
Y

Yuqin Cao

Shanghai Jiao Tong University
H指数:16
被引数:820

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Preoperative pembrolizumab (anti-PD-1 antibody) combined with chemoradiotherapy for esophageal squamous cell carcinoma: a phase 1/2 trial (PALACE-2)

术前pembrolizumab (anti-PD-1抗体) 联合放化疗治疗食管鳞癌1/2期临床试验 (PALACE-2)

2025-11-280
OAAI
Neoadjuvant camrelizumab combined with chemoradiotherapy and watch-and-wait strategy versus neoadjuvant chemoradiotherapy followed by surgery in locally advanced oesophageal squamous cell carcinoma: study protocol of a randomised controlled trial (PALACE-3)

新辅助卡瑞利珠单抗联合化放疗与观察等待策略 versus 新辅助化放疗后手术在局部晚期食管鳞状细胞癌中的应用:一项随机对照试验的研究方案(PALACE-3)

2025-10-150
OA
Updated protocol of the POINT trial: a multicenter randomized controlled trial investigating effects of preoperative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy

POINT临床试验方案更新:一项多中心随机对照试验,旨在研究新辅助放化疗治疗的食管癌患者术前肠内免疫营养的影响

2025-10-100
OAAI
Robotic-assisted versus video-assisted lobectomy for resectable non-small-cell lung cancer: the RVlob randomized controlled trial
2024-08-010
OAAI
Online tools to predict individualised survival for primary oesophageal cancer patients with and without pathological complete response after neoadjuvant therapy followed by oesophagectomy: development and external validation of two independent nomograms
2024-03-271
OAAI
Effects of pre-operative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy: protocol for a multicenter randomized controlled trial (point trial, pre-operative immunonutrition therapy)
2022-06-1310
OAAI
A combination model of AD biomarkers revealed by machine learning precisely predicts Alzheimer's dementia: China Aging and Neurodegenerative Initiative (CANDI) study

通过机器学习揭示的AD生物标志物组合模型可精确预测阿尔茨海默氏痴呆症: 中国老龄化和神经退行性疾病倡议 (CANDI) 研究

2022-06-0634
PRE